三回分层预测了ACE-I/ARB患者中系统右心室功能障碍的时间过程
Kohsaku Goto1, Katsura Soma1, Hiroyuki Tokiwa1,2
1Department of Cardiovascular Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
CJC pediatric and congenital heart disease
|December 2, 2024
概括
三回的严重程度预测了在接受ACE-I/ARB治疗的患有先天性心脏病的成年人中右心室功能变化. 轻度TR改善了右心室喷射率,而中度/重度TR没有显示这些好处.
科学领域:
- 心脏病学 心脏病学
- 成年人的先天性心脏病
- 心脏成像 - - 心脏成像
背景情况:
- 系统右心室 (sRV) 功能障碍是成人先天性心脏病的一个主要问题.
- 目前的心力衰竭药物指南缺乏针对sRV患者的具体建议.
- 心脏磁共振 (CMR) 提供了对复杂的心脏异常至关重要的定量评估.
研究的目的:
- 在接受血管素转化酶抑制剂/血管素受体抑制剂 (ACE-I/ARB) 治疗的患者中,确定sRV功能障碍的预后因素.
- 使用CMR衍生的定量值来评估sRV函数及其预测因素.
主要方法:
- 对17名在ACE-I/ARB治疗中出现sRV的成年患者进行了回顾性队列研究.
- 后勤回归分析以确定与sRV射出分数 (sRVEF) 恶化相关的因素.
- 主要结局:在平均68.7个月的随访期间,sRVEF的恶化.
主要成果:
- 在随访期间,17%的患者出现sRVEF恶化.
- 三腹 (TR) 被确定为潜在的独立预后因素 (OR = 1.11).
- 轻度TR患者 (≤15%) 的sRVEF和中风体积显著改善,与中度/重度TR患者 (>16%) 不同.
结论:
- 基于CMR的评估和TR分层可以预测ACE-I/ARB的sRV患者的sRVEF变化.
- 需要进一步的随机对照试验,包括TR严重程度,以澄清ACE-I/ARB治疗的作用.
相关概念视频
01:20Mitral Regurgitation I: Introduction
2
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
2
01:15Aortic Regurgitation I: Introduction
2
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
2
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
385
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
385
01:25Mitral Regurgitation III: Medical Management
4
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
4
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
2
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
2
01:17Aortic Regurgitation IV: Nursing Management
9
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
9